Filing Details
- Accession Number:
- 0001213900-20-009743
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-21 17:10:31
- Reporting Period:
- 2020-02-20
- Accepted Time:
- 2020-04-21 17:10:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1780262 | Newborn Acquisition Corp | NBAC | Blank Checks (6770) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1803181 | Neogenesis Holding Co. Ltd. | Room 801, Building C Soho Square, No. 88 Zhongshan East 2Nd Road, Huangpu Dt. Shanghai F4 200002 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2020-02-20 | 272,500 | $10.00 | 1,645,000 | No | 4 | P | Direct | |
Ordinary Shares | Disposition | 2020-04-20 | 100,000 | $0.00 | 1,545,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Warrants to purchase Ordinary Shares | Acquisiton | 2020-02-20 | 272,500 | $0.00 | 136,250 | $11.50 |
Ordinary Shares | Rights to acquire Ordinary Shares | Acquisiton | 2020-02-20 | 272,500 | $0.00 | 27,250 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
272,500 | No | 4 | P | Direct | ||
272,500 | No | 4 | P | Direct |
Footnotes
- The reporting person acquired 272,500 units consisting of ordinary shares ,warrants and rights at a purchase price of $10.00 per unit.
- The warrants become exercisable on the later of (i) the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.
- The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.
- The rights convert automatically into ordinary shares at the completion of the registrant's initial business combination.